BiotechTube

JR-446

Phase 1/2Recruiting
0 watching 0 views this week⚡ Active
40
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Mucopolysaccharidosis III-B

Conditions

Mucopolysaccharidosis III-B

Trial Timeline

Nov 5, 2024 → Apr 30, 2030

NCT ID
NCT06488924

About JR-446

JR-446 is a phase 1/2 stage product being developed by JCR Pharmaceuticals for Mucopolysaccharidosis III-B. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06488924. Target conditions include Mucopolysaccharidosis III-B.

Hype Score Breakdown

Clinical
13
Activity
8
Company
9
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT06488924Phase 1/2Recruiting

Competing Products

20 competing products in Mucopolysaccharidosis III-B

See all competitors
ProductCompanyStageHype Score
OdiparcilInventivaPhase 2
47
anakinraSwedish Orphan BiovitrumPhase 1/2
40
laronidaseSanofiApproved
84
LaronidaseSanofiApproved
84
Aldurazyme (Recombinant Human Alpha-L-Iduronidase) + Aldurazyme (Recombinant Human Alpha-L-Iduronidase)SanofiPhase 2
51
Aldurazyme (Recombinant Human Alpha-L-Iduronidase) + Aldurazyme (Recombinant Human Alpha-L-Iduronidase) + Aldurazyme (Recombinant Human Alpha-L-Iduronidase) + Aldurazyme (Recombinant Human Alpha-L-Iduronidase)SanofiApproved
84
Laronidase + Cyclosporine A (CsA) + Azathioprine (Aza)SanofiPhase 1/2
40
Aldurazyme (Recombinant Human Alpha-L-Iduronidase)SanofiPhase 3
76
rhIDU (recombinant human-Alpha-L-Iduronidase) + PlaceboSanofiPhase 3
76
Aldurazyme + Aldurazyme + placeboSanofiPhase 3
76
LaronidaseSanofiApproved
84
JR-141JCR PharmaceuticalsPhase 2/3
64
JR-441 + JR-441 + JR-441JCR PharmaceuticalsPhase 1/2
40
JR-171JCR PharmaceuticalsPhase 1/2
40
JR-141JCR PharmaceuticalsPhase 2
51
JR-141 + Idursulfase + JR-141 or IdursulfaseJCR PharmaceuticalsPhase 3
76
JR-141JCR PharmaceuticalsPhase 3
76
JR-171 (lepunafusp alfa)JCR PharmaceuticalsPhase 1/2
40
JR-141JCR PharmaceuticalsPhase 1/2
40
JR-141JCR PharmaceuticalsPhase 2/3
64

Other Products from JCR Pharmaceuticals

JR-141 + Idursulfase + JR-141 or IdursulfasePhase 3
76
JR-141Phase 3
76
JR-141Phase 2/3
64
JR-141Phase 2/3
64
JR-141Phase 2
51